SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc – ‘10-K’ for 12/31/12

On:  Friday, 3/15/13, at 4:50pm ET   ·   For:  12/31/12   ·   Accession #:  1193125-13-110112   ·   File #:  0-19627

Previous ‘10-K’:  ‘10-K/A’ on 7/6/12 for 12/31/11   ·   Next:  ‘10-K’ on 3/17/14 for 12/31/13   ·   Latest:  ‘10-K’ on 3/8/19 for 12/31/18

  in    Show  and    Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/15/13  Biolase, Inc                      10-K       12/31/12   76:8.5M                                   Donnelley … Solutions/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.11M 
 2: EX-21.1     Subsidiaries                                        HTML     20K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML     22K 
 4: EX-31.1     Certification -- Sarbanes-Oxley Act - Sect. 302     HTML     26K 
 5: EX-31.2     Certification -- Sarbanes-Oxley Act - Sect. 302     HTML     27K 
 6: EX-32.1     Certification -- Sarbanes-Oxley Act - Sect. 906     HTML     23K 
 7: EX-32.2     Certification -- Sarbanes-Oxley Act - Sect. 906     HTML     23K 
52: R1          Document and Entity Information                     HTML     53K 
41: R2          Consolidated Balance sheets                         HTML    144K 
50: R3          Consolidated Balance sheets (Parenthetical)         HTML     51K 
54: R4          Consolidated Statements of Operations and           HTML    121K 
                          Comprehensive Loss                                     
70: R5          Consolidated Statements of Shareholders' Equity     HTML     97K 
                          (Deficit)                                              
43: R6          Consolidated Statements of Cash Flows               HTML    180K 
49: R7          Basis Of Presentation                               HTML     42K 
37: R8          Summary Of Significant Accounting Policies          HTML     97K 
28: R9          Supplementary Balance Sheet Information             HTML     68K 
71: R10         Intangible Assets And Goodwill                      HTML     51K 
56: R11         Lines Of Credit And Other Borrowings                HTML     36K 
55: R12         Income Taxes                                        HTML     87K 
61: R13         Commitments And Contingencies                       HTML     38K 
62: R14         Stockholders' Equity                                HTML    109K 
59: R15         Segment Information                                 HTML     37K 
63: R16         Concentrations                                      HTML     25K 
51: R17         Non-Recurring Event                                 HTML     25K 
53: R18         Subsequent Events                                   HTML     24K 
58: R19         Schedule II-Consolidated Valuation and Qualifying   HTML     41K 
                          Accounts and Reserves                                  
76: R20         Basis Of Presentation (Policies)                    HTML    242K 
66: R21         Summary Of Significant Accounting Policies          HTML     60K 
                          (Tables)                                               
46: R22         Supplementary Balance Sheet Information (Tables)    HTML     73K 
57: R23         Intangible Assets And Goodwill (Tables)             HTML     43K 
48: R24         Income Taxes (Tables)                               HTML     84K 
22: R25         Commitments And Contingencies (Tables)              HTML     26K 
67: R26         Stockholders' Equity (Tables)                       HTML     83K 
73: R27         Segment Information (Tables)                        HTML     30K 
32: R28         Schedule II-Consolidated Valuation and Qualifying   HTML     39K 
                          Accounts and Reserves (Tables)                         
31: R29         Basis of Presentation - Additional Information      HTML     55K 
                          (Detail)                                               
35: R30         Estimated Useful Lives Of Property, Plant and       HTML     28K 
                          Equipment (Detail)                                     
36: R31         Summary of Significant Accounting Policies -        HTML     98K 
                          Additional Information (Detail)                        
38: R32         Accrued Liabilities - Changes In Initial Product    HTML     41K 
                          Warranty Accrual and Expenses Under                    
                          Initial and Extended Warranties (Detail)               
20: R33         Classification Of Compensation Expense Associated   HTML     32K 
                          With Share-Based Payments (Detail)                     
64: R34         Assumptions Used in Estimating Fair Value Of Stock  HTML     34K 
                          Options Granted (Detail)                               
45: R35         Components of Accounts Receivable, Net of           HTML     30K 
                          Allowance (Detail)                                     
47: R36         Supplementary Balance Sheet Information -           HTML     52K 
                          Additional Information (Detail)                        
25: R37         Components of Inventory (Detail)                    HTML     34K 
75: R38         Summary of Property,Plant and Equipment (Detail)    HTML     39K 
14: R39         Components of Accrued Liabilities (Detail)          HTML     50K 
39: R40         Summary of Deferred Revenue (Detail)                HTML     40K 
69: R41         Intangible Assets And Goodwill - Additional         HTML     47K 
                          Information (Detail)                                   
24: R42         Intangible Assets Related to Accumulated            HTML     55K 
                          Amortization and Goodwill (Detail)                     
30: R43         Lines Of Credit And Other Borrowings - Additional   HTML    129K 
                          Information (Detail)                                   
34: R44         Summary of Income Tax Current and Deferred          HTML     65K 
                          Provision (Benefit) (Detail)                           
42: R45         Federal Income Tax Provision Compared With          HTML     63K 
                          Statutory Rates (Detail)                               
19: R46         Summary of Net Deferred Tax Assets and Net          HTML     83K 
                          Deferred Tax Liabilities (Detail)                      
27: R47         Income Taxes - Additional Information (Detail)      HTML     61K 
16: R48         Summary of Unrecognized Tax Benefits (Detail)       HTML     31K 
68: R49         Commitments And Contingencies - Additional          HTML     38K 
                          Information (Detail)                                   
23: R50         Future Minimum Rental Commitments Under Operating   HTML     46K 
                          Lease Agreements (Detail)                              
65: R51         Stockholders' Equity - Additional Information       HTML    163K 
                          (Detail)                                               
26: R52         Summary of Option Activity (Detail)                 HTML     83K 
40: R53         Options Outstanding and Exercisable (Detail)        HTML     70K 
15: R54         Cash Proceeds Along With Fair Value Disclosures     HTML     41K 
                          Related to grants Exercises And Vesting                
                          Options (Detail)                                       
17: R55         Segment Information - Additional Information        HTML     33K 
                          (Detail)                                               
33: R56         Summary of Net Revenue by Geographic Location       HTML     27K 
                          (Detail)                                               
21: R57         Concentrations - Additional Information (Detail)    HTML     37K 
72: R58         Non Recurring Event - Additional Information        HTML     36K 
                          (Detail)                                               
44: R59         Subsequent Events - Additional Information          HTML     30K 
                          (Detail)                                               
60: R60         Consolidated Valuation and Qualifying Accounts and  HTML     36K 
                          Reserves (Detail)                                      
74: XML         IDEA XML File -- Filing Summary                      XML    115K 
29: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.02M 
 8: EX-101.INS  XBRL Instance -- biol-20121231                       XML   1.69M 
10: EX-101.CAL  XBRL Calculations -- biol-20121231_cal               XML    252K 
11: EX-101.DEF  XBRL Definitions -- biol-20121231_def                XML   1.10M 
12: EX-101.LAB  XBRL Labels -- biol-20121231_lab                     XML   1.77M 
13: EX-101.PRE  XBRL Presentations -- biol-20121231_pre              XML   1.22M 
 9: EX-101.SCH  XBRL Schema -- biol-20121231                         XSD    256K 
18: ZIP         XBRL Zipped Folder -- 0001193125-13-110112-xbrl      Zip    218K 





Filing Submission 0001193125-13-110112 – SGML Text

Original SGML Text submitted by:  Donnelley Financial Solutions/FA  (as Filing Agent)

To view the SGML, please refresh
Counterclockwise arrows button emoji
this page.


Top

Copyright © 2020 Fran Finnegan & Company.  All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Jan. 24, 11:41:04.2am ET